Stockreport

Vaccinex, Inc. to Present at CHDI’s 17th Annual HD Therapeutics Conference Meeting

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treati [Read more]